Reduction in p140-trkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease

Experimental Neurology

Volumn 146, Issue 1, 1997, Pages 91-103

  Mufson, Elliott J ^a   Lavine, Natalie ^b   Jaffar, Syed ^a   Kordower, Jeffrey H ^a   Quirion, Rémi ^b,c   Saragovi, H Uri ^b,d  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OLIVARY NUCLEUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION;

EID: 0031194454     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6504     Document Type: Article

References (46)

1. 1. Barker, B. A., and E. M. Shooter. 1994. Distribution of NGF binding to the low affinity neurotrophin receptor p75 LNTR reduces NGF binding to trkA on PC12 cells. Neuron 13: 203-215.
2. 2. Bierer, L. M., V. Haroutunian, S. Gabreil, P. J. Knott, L. S. Carlin, D. P. Purohit, D. P. Perl, J. Schmeidler, P. Kanof, and K. L. Davis. 1995. Neurochemical correlates of dementia in Alzheimer's disease: Relative importance of cholinergic deficits. J. Neurochem. 64: 749-760.
3. 3. Boissiere, B., Y. Faucheux, Y. Agid, and E. C. Hirsch. 1996. Decrease of trkA mRNA level in cholinergic neurons of the striatum and basal forebrain in Alzheimer's disease. Soc. Neurosci. Abstr. 22: 210.
4. 4. Connor, B., D. Young, P. Lawlor, W. Gai, H. Waldvogel, R. L. M. Faull, and M. Dragunow. 1996. Trk receptor alterations in Alzheimer's disease. Mol. Brain Res. 42: 1-17.
5. 125I] nerve growth factor by cholinergic neurons and down-regulated TrkA expression in the medial septum of aged rats. Neuroscience 62: 625-639.
6. 6. Crutcher, K. A., S. A. Scott, S. Liang, W. V. Everson, and J. Weingarten. 1993. Detection of NGF-like activity in human brain tissue: Increased levels in Alzheimer's disease. J. Neurosci. 13: 2540-2550.
7. 7. DeKosky, S. T., S. W. Scheff, and W. R. Markesbery. 1985. Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging. Neurology 35: 1425-1431.
8. 8. DiStefano, P. S., B. Friedman, A. C. Radziejieski, P. Boland, C. M. Schick, R. M. Lindsay, and S. J. Wiegand. 1992. The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron 8: 983-993.
9. 9. Ernfors, P., N. Lindefors, V. Chan-Palay, and H. Persson. 1990. Cholinergic neurons of the nucleus basalis express elevated levels of nerve growth factor receptor mRNA in senile dementia of the Alzheimer's type. Dementia 1: 138-145.
10. 10. Fischer, W., K. Wictorin, A. Bjorklund, L. R. Williams, S. Varon, and F. H. Gage. 1987. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329: 65-68.
11. 11. Gibbs, R. B., and D. W. Pfaff. 1994. In situ hybridization detection of trkA mRNA in brain: Distribution, colocalization with p75NGFR and up-regulation by nerve growth factor. J. Comp. Neurol. 341: 324-339.
12. 12. Goedert, M., A. Fine, S. P. Hunt, and A. Ullrich. 1986. Nerve growth factor RNA in peripheral and rat central tissues and in the human central nervous system: Lesion effects in the rat brain and levels in Alzheimer's disease. Mol. Brain Res. 1: 85-92.
13. 13. Higgins, G. A., and E. J. Mufson. 1989. NGF receptor gene expression is decreased in the nucleus basalis in Alzheimer's disease. Exp. Neurol. 106: 222-236.
14. 14. Holtzman, D. M., J. Kilbridge, Y. Li, E. T. Cunningham Jr., N. J. Lenn, D. O. Clary, L. F. Reichardt, and W. C. Mobley. 1995. TrkA expression in the CNS: Evidence for the existence of several novel NGF-responsive CNS neurons. J. Neurosci. 15: 1567-1676.
15. 15. Jing, S., P. Tapley, and M. Barbacid. 1993. Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron 9: 1067-1979.
16. 16. Khachaturian, Z. S. Diagnosis of Alzheimer's disease. 1983. Arch. Neurol. 42: 1097-1105.
17. 17. Koh, S., G. A. Oyler, and G. A. Higgins. 1989. Localization of nerve growth factor receptor messenger RNA and protein in the adult rat brain. Exp. Neurol. 106: 209-221.
18. 18. Kordower, J. H., R. T. Bartus, M. Bothwell, G. Schatteman, and D. M. Gash. 1988. Nerve growth factor receptor immunoreactivity in the nonhuman primate (Cebus apella): Distribution, morphology, and colocalization with cholinergic enzymes. J. Comp. Neurol. 277: 465-486.
19. 19. Kordower, J. H., E.-Y. Chen, J. R. Sladek Jr., and E. J. Mufson. 1994. Trk-immunoreactivity in the monkey central nervous system. I. Forebrain. J. Comp. Neurol. 349: 20-35.
20. 20. Kordower, J. H., D. M. Gash, M. Bothwell, L. Hersh, and E. J. Mufson. 1989. Nerve growth factor receptor and choline acetyltransferase remain colocalized in the nucleus basalis (Ch4) of Alzheimer's patients. Neurobiol. Aging 10: 287-294.
21. 21. Kordower, J. H., and E. J. Mufson. 1989. NGF and Alzheimer's disease: Unfulfilled promise and untapped potential. Neurobiol. Aging 10: 543-544.
22. 22. Kordower, J. H., S. R. Winn, Y.-T. Liu, E. J. Mufson, J. R. Sladek Jr., J. P. Hammang, E. E. Baetge, and D. F. Emerich. 1994. The aged monkey basal forebrain: Rescue and sprouting of degenerating cholinergic neurons following grafts of polymer-encapsulated human NGF secreting cells. Proc. Natl. Acad. Sci. USA 91: 10898-10902.
23. 23. LeSauteur, L., S. Maliartchouk, H. Lejeune, R. Quirion, and H. U. Saragovi. 1996. Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody. J. Neurosci. 16: 1308-1316.
24. 24. Li, Yiwen, D. Holtzman, L. F. Kromer, D. R. Kaplan, J. Chua-Couzens, D. O. Clary, Knusel, and W. C. Mobley. 1995. Regulation of trkA and ChAT expression in developing rat basal forebrain: Evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons. J. Neurosci. 15: 2888-2905.
25. 25. McGeer, P. L., E. G. McGeer, J. Suzuki, C. E. Dolman, and T. Nagai. 1984. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain. Neurology 34: 741-745.
26. 26. Mesulam, M. M., E. J. Mufson, A. I. Levey, and B. H. Wainer. 1983. Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J. Comp. Neurol. 214: 170-197.
27. 27. Mufson, E. J., M. Bothwell, and J. H. Kordower. 1989. Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: A quantitative analysis across subregions of the basal forebrain. Exp. Neurol. 105: 221-232.
28. 28. Mufson, E. J., M. Bothwell, L. B. Hersh, and J. H. Kordower. 1989. Nerve growth factor receptor immunoreactive profiles in the normal aged human basal forebrain: Colocalization with cholinergic neurons. J. Comp. Neurol. 285: 196-217.
29. 29. Mufson, E. J., E. Cochran, W. C. Benzing, and J. H. Kordower. 1993. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the striia terminalis in aging, Alzheimer's disease and Down's syndrome. Dementia 4: 237-250.
30. 30. Mufson, E. J., J. M. Connor, and J. H. Kordower. 1995. NGF and Alzheimer's disease: Defective retrograde transport to the nucleus basalis. Neuroreport 6: 1063-1066.
31. 31. Mufson, E. J., J. M. Connor, J. S. Varon, and J. H. Kordower. 1994. Nerve growth factor immunoreactivity in the basal forebrain and hippocampus in primates and Alzheimer's disease. J. Comp. Neurol. 341: 507-519.
32. 32. Mufson, E. J., W. C. Benzing, G. M. Cole, H. Wang, D. F. Emerich, J. R. Sladek Jr., J. H. Morrison, and J. H. Kordower. 1994. Apolipoprotein E-immunoreactivity in aged rhesus monkey cortex: Colocalization with amyloid plaques. Neurobiol. Aging 15: 621-627.
33. 33. Mufson, E. J., J.-M. Li, T. Sobreviela, and J. H. Kordower. 1996. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease. Neuroreport 7: 25-29, 1996.
34. 34. Nalbantoglu, J., B. M. Gilfix, P. Bertrand, Y. Robitaille, S. Gauthier, D. S. Rosenblatt, and J. Poirier. 1994. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: Results of an autopsy series and an analysis of several combined studies. Ann. Neurol. 36: 889-895.
35. 35. Rosene, D. L., N. J. Roy, and B. J. Davis. 1986. A cryoprotection method that facilitates cutting frozen sections of whole monkey brains for histological and histochemical processing without freezing artifact. J. Histochem. Cytochem. 34: 1301-1315.
36. 36. Salehi, A., J. Verhaggen, P. A. Dijhuizen, and D. F. Swaab. 1996. Colocalization of high affinity neurotrophin receptors in nucleus basalis of meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience 75: 373-387.
37. 37. Schatteman, G. C., L. Gibbs, A. A. Lanaham, P. Claude, and M. Bothwell. 1988. Expression of NGF receptor in the developing and adult primate central nervous system. J. Neurosci. 8: 860-873.
38. 38. Scott, S. A., E. J. Mufson, J. A. Weingartner, K. A. Skau, and K. A. Crutcher. 1995. Nerve growth factor in Alzheimer's disease: Increased levels throughout the brain coupled with declines in nucleus basalis. J. Neurosci. 15: 6213-6221.
39. 39. Seiler, M., and M. E. Schwaab. 1984. Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res. 300: 33-39.
40. 40. Shelton, D. L., J. Sutherland, J. Gripp, T. Camerato, M. Armanini, H. Philips, K. Carroll, S. D. Spencer, and A. D. Levinson. 1995. Human trks - Molecular cloning, tissue distribution and expression of extracellular domain immunoadhesions. J. Neurosci. 15: 477-491.
41. 41. Sobreviela, T., D. O. Clary, L. F. Reichardt, M. M. Brandabur, J. H. Kordower, and E. J. Mufson. 1994. TrkA immunoreactive profiles in the central nervous system: Colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase and serotonin. J. Comp. Neurol. 350: 587-611.
42. 42. Steininger, T. L., B. H. Wainer, R. Klein, M. Barbacid, and H. C. Palfrey. 1993. High affinity nerve growth factor receptor (Trk) immunoreactivity is localized in cholinergic neurons of the basal forebrain and striatum in the adult rat brain. Brain Res. 612: 330-335.
43. 43. Tuszynski, M. H., H. Sang, K. Yoshida, and F. H. Gage. 1991. Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the primate brain. Ann. Neurol. 30: 625-636.
44. 44. Whitehouse, P. J., D. L. Price, R. G. Struble, A. W. Clarke, J. T. Coyle, and M. R. Delon. 1982. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 215: 1237-1239.
45. 45. Wilcock, G. K., M. M. Esiri, D. M. Bowen, and C. C. Smith. 1982. Alzheimer's disease: Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J. Neurol. Sci. 57: 407-417.
46. 46. Whittemore, S. R., T. Ebendal, L. Larkfort, L. Olson, A. Seiger, I. Sromberg, and H. Persson. 1986. Developmental and regional expression of β nerve growth factor messenger RNA and protein in the rat central nervous system. Proc. Natl. Acad. Sci. USA 83: 817-821.